PRIMARY CARE
At MD 2.0, we provide patients with superior primary care. We want to be the first to know about any health concerns that may arise. Primary care is performed and managed by your personal physician, Dr. Poncy or Dr. Lubarsky who are available to you 24/7.
PREVENTATIVE HEALTH
Drs. Lubarsky and Poncy believe in more than just treating you when you are sick. Our preventative medicine doctors want to ensure you are healthy year round by promoting a healthy lifestyle, yearly executive level physical exams, and helping to prevent disease.
INTERNAL MEDICINE
At MD 2.0, our concierge physician practice focuses on providing high quality care and individualized attention to each patient. Our model allows us to spend more time with each patient, allowing us to work closely with you on prevention, diagnosis, and treatment of diseases and complex illnesses.
Meet Our Doctors
Dr. Amir Lubarsky
Board Certified Internist in Jupiter, FL
Dr. Amir Lubarsky's love of medicine allows him to listen compassionately and intently to his patients in order to provide the best outcomes.Dr. Morgan Poncy
Board Certified Internal Medicine Doctor in Jupiter, FL
Dr. Morgan Poncy is a board certified internist who was raised in the Jupiter area.LATEST NEWS
Strep Throat Complications
In response to the tragic story from Arizona, where a young girl suffered severe complications from a group A streptococcus infection, it is crucial to understand the seriousness of what is often perceived as a common and manageable illness. Our concierge doctors want to remind you of the importance of timely medical intervention and the potential severity of strep throat, especially in atypical, severe cases.
Understanding Strep Throat and Its Impact: Strep throat, caused by the bacterium group A streptococcus, is primarily known for symptoms like sore throat, fever, and swollen lymph nodes. While most cases are mild and effectively treated with antibiotics, the condition can lead to severe complications if not addressed promptly.
A Heartbreaking Case from Arizona: The case of a 7-year-old girl in Arizona underscores the potentially devastating outcomes of a severe strep A infection. Despite what began as typical symptoms, her condition rapidly escalated, leading to multiple amputations. This extreme situation highlights the critical need for awareness and vigilance among parents and caregivers.
The Risks of Untreated Strep Infections: When untreated, strep throat can cause significant harm beyond the initial symptoms, affecting the kidneys, heart, and other vital organs. It emphasizes the necessity of early diagnosis and treatment to prevent such dire consequences.
Preventative Measures and Awareness: The highly contagious nature of strep throat calls for informed preventative strategies to mitigate its spread, especially among vulnerable populations. Recognizing symptoms early and seeking prompt medical advice are key steps in preventing severe outcomes.
Community and Healthcare Provider Roles: Healthcare providers in Jupiter, Florida, and elsewhere play a pivotal role in educating the community, identifying strep throat cases early, and providing effective treatment. They also have the responsibility to communicate the potential risks associated with delayed care.
Takeaways for Jupiter, Florida, Residents: Residents should be attentive to the symptoms of strep throat, particularly in children, and seek medical advice promptly. The healthcare community in Jupiter should continue to emphasize the importance of early intervention and educate parents on the signs to watch for, reinforcing that while rare, severe complications can occur.
In conclusion, the heartbreaking story from Arizona is a call to action for increased awareness and proactive healthcare engagement. By understanding the risks and maintaining vigilance against strep throat, communities like Jupiter can better protect their residents and prevent tragic outcomes.
The FDA Approves Wegovy for Heart Disease
As a primary care concierge service committed to providing our patients with the latest and most effective healthcare solutions, we are thrilled to discuss a groundbreaking development in the realm of cardiovascular health. The U.S. Food and Drug Administration (FDA) has recently approved Wegovy, a medication initially designed for weight loss, as a preventative treatment for heart disease in specific patient populations. This approval marks a significant milestone in the battle against cardiovascular diseases and opens new doors for patient care in our practice.
Wegovy, an injectable semaglutide, has already made a name for itself in the weight loss domain. Its efficacy for certain patients in reducing weight is well recognized. However, its latest approval stems from its capability to diminish the risk of cardiovascular death, heart attacks, and strokes in adults who have cardiovascular disease and are either overweight or obese. As articulated by John Sharretts, M.D., the director of the Division of Diabetes, Lipid Disorders, and Obesity at the FDA, this patient demographic faces an elevated risk of severe cardiovascular events. The introduction of Wegovy as a treatment option that can mitigate this risk is indeed a monumental stride in enhancing public health.
The approval of Wegovy for cardiovascular disease prevention is grounded in robust scientific evidence. A substantial, randomized, double-blind trial involving 17,600 participants evaluated the efficacy of Wegovy in conjunction with standard care, including blood pressure and cholesterol management and lifestyle counseling. The results were compelling; the group using Wegovy exhibited a significant reduction in life-threatening cardiovascular incidents.
At our concierge medical practice, we understand the significance of this development, especially for patients struggling with heart disease alongside being overweight or obese. Brooke Boyarsky Pratt, the CEO of Knownwell, highlighted this approval as an "exciting day" for such patients and their healthcare providers, emphasizing the critical role of GLP-1 receptor agonists in managing chronic conditions beyond diabetes and obesity.
The endorsement of Wegovy also addresses the prevailing bias and stigma associated with medications for weight management, underscoring their potential to address severe health risks. Dr. Darren McGuire from UT Southwestern lauded the FDA's decision as pivotal, noting that semaglutide is now the first U.S.-approved medication promising more than just cardiovascular safety for individuals living with obesity.
Looking forward, we anticipate more innovations in this therapeutic area, as Dr. McGuire predicts an influx of similar medications. For our patients, this development signifies an expanded arsenal against cardiovascular diseases, offering new hope and treatment possibilities.
As always, we are here to guide our patients through these new treatment options, evaluating the benefits and potential side effects to tailor the best possible care plans. If you or a loved one could benefit from Wegovy or have concerns about cardiovascular risks, we encourage you to reach out to us. Together, we can navigate these new advancements and continue our mission of providing exceptional, personalized healthcare.
For those interested in further discussions or consultations regarding Wegovy or other cardiovascular prevention strategies, please feel free to contact our office. Your health and well-being remain our utmost priority, and we are committed to keeping you informed and cared for with the latest medical advancements.
My husband and I have been patients of Dr. Poncy for over ten years and have been extremely pleased and happy for him. He is not only a brilliant internist, but also a wonderful person. Now that he and his partner, Dr. Lubarsky, have opened the concierge practice it is better than ever. The nursing staff is superlative as is the front office staff. The office is very well appointed and comfortable. We feel very fortunate to have such a competent and caring physician.
About 11 years ago, I first met with Dr. Poncy. I came away from my appointment with him confident he understood my problem and contributed some thoughtful suggestions. Over the years, he has never changed. The outstanding staff Dr. Poncy has put together, along with his partner, Dr. Lubarsky, are the best! I honestly feel, when I have an appointment, it is like visiting "family".
I recommend Dr Lubarsky emphatically. He is a true professional: thorough, compassionate and an excellent diagnostician!
We have been concierge members for only 6 months but so far we have been very pleased. The office atmosphere is very relaxed and the doctor is able to give us the time we need. Time in the waiting room is minimal and we have been able to obtain spur of the moment appointments with no difficulty. We are happy that we joined
The new practice has a very warm, friendly, feeling to it. We don't have long waiting times. Everyone is very prompt.
I have been a patient for over 30 years. I actually look forwarded to a visit. Pleasant, professional in every way, I consider myself very lucky.
A great Dr. & great staff, minimum wait time. Spends as much time with you as you need. Same day appointments.
Dr. Poncy has been my primary care doctor for over 8 years. I've known Dr. Poncy for over 8 years. My neighbor recommended him for my diabetes and heart problem. The staff at Dr. Poncy's office is always very pleasant and Dr. Poncy is very patient to my concerns.
I have been a patient of Dr. Lubarsky since 2004. He has been such a great physician to me and my wife for several years. Recently, I was hospitalized at Jupiter Medical Center. My wife contacted him and he immediately responded and came to the hospital. Without Dr. Lubarsky's support, I don't think I would be at the health level I am at today.
I'm a big fan of Dr. Lubarsky! After moving from New York, I researched area Internist throughout Jupiter and Palm Beach Gardens. Dr. Lubarsky was a home run!